Business Context and Reporting Period
This Form 8-K is a current report filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) on June 15, 2018, covering events occurring on June 14, 2018. The filing addresses corporate governance changes and dividend declarations.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to dividend declarations:
- Common Stock Dividend: $0.20 per share for the second quarter of 2018.
- Series A Preferred Stock Dividend: $0.46875 per share for the period April 30, 2018, through July 30, 2018.
Material Changes
The primary material change reported is the appointment of Paula Crowley as a director of the Company on June 14, 2018. Upon appointment, she became eligible for the annual compensation granted to independent directors and was assigned to the Audit Committee and Investment Committee. No other material financial changes or transactions exceeding $120,000 involving Ms. Crowley were reported.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond standard regulatory disclosures. The document notes that the press release regarding the director appointment is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Global Medical REIT Inc., as the input metadata referenced Chiron Real Estate Inc.
- Confirm the record dates for the declared dividends: June 26, 2018 (Common) and July 15, 2018 (Series A Preferred).
- Review the Definitive Proxy Statement on Schedule 14A (filed April 19, 2018) for details on the compensation package for independent directors.
- Note that this filing does not contain updated financial performance data; refer to the most recent 10-Q or 10-K for revenue and liquidity metrics.